Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevudine Long-Term Efficacy in Chronic Hepatitis B
NCT01264094Phase 4Terminated
- Sponsor
- Bukwang Pharmaceutical
- Start
- Nov 2009
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clevudine in Chronic Hepatitis B (CHB), sponsored by Bukwang Pharmaceutical. Started Nov 2009; status: terminated.
02
Drugs
clevudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01264094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01264094.